Expert perspectives on cholangiocarcinoma (CCA)

Intended for UK healthcare professionals only

Multidisciplinary team approach in CCA (2 videos)

Select a category

View all Cancer of unknown primary (CUP) Multidisciplinary team approach in CCA Overview of CCA Precision medicine and molecular profiling in CCA Symposia highlights

Optimising molecular profiling and the multidisciplinary team approach in cholangiocarcinoma (ESMO 2022)

Dr Angela Lamarca

Fundación Jiménez Díaz University Hospital, Spain

Dr David Malka

Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France
INSERM U1279, Villejuif, Université Paris-Saclay, France

Disclosures

Dr Angela Lamarca:

Company/Organisation	Relationship(s)
Albireo Pharma, AstraZeneca, Boehringer Ingelheim, Boston Scientific, Eisai, GenFit, Nutricia Ipsen, QED, Roche, Servier and TransThera Biosciences	Receipt of honoraria or consultation fees
AAA, AstraZeneca, Eisai, Incyte, Ipsen, Merck, Pfizer, QED, Roche and Servier	Participation in company-sponsored speaker bureau
AAA, Bayer, Delcath, Ipsen, Mylan, Novartis, Pfizer and Sirtex	Travel, education funding
Ipsen and Roche	Research funding

Disclosures

Dr David Malka:

Company/Organisation	Relationship(s)
AbbVie, Agios, Amgen, AstraZeneca, Bayer, BMS, HalioDx, Incyte, Merck Serono, MSD, Pierre Fabre Oncologie, Roche, Sanofi, Servier, Taiho	Consulting/advisory role
Amgen, AstraZeneca, Bayer, BMS, Foundation Medicine, HalioDx, Incyte, Leo Pharma, Merck Serono, MSD, Pierre Fabre Oncologie, Roche, Sanofi, Servier, Veracyte, Viatris	Honoraria for lectures
Medscape	Personal fees for a writing engagement
Travel expenses	Amgen, Bayer, BMS, Merck Serono, MSD, Pierre Fabre Oncologie, Roche, Sanofi, Servier, Viatris

This website has been created and funded by Incyte.

If you would like to request further medical information, please visit:
www.incyteglobalmedicalinformation.com